Business Description
Quantum BioPharma Ltd
NAICS : 325412
SIC : 3741
ISIN : CA35954B1076
Share Class Description:
QNTM: Ordinary Shares - Class B (Sub Voting)Compare
Compare
Traded in other countries / regions
QNTM.CanadaQNTM.USA0K91.Germany IPO Date
2018-06-07Description
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.32 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 41 | |||||
| 3-Year EPS without NRI Growth Rate | 47.3 | |||||
| 3-Year FCF Growth Rate | 43.5 | |||||
| 3-Year Book Growth Rate | -42.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.18 | |||||
| 9-Day RSI | 54.96 | |||||
| 14-Day RSI | 53.55 | |||||
| 6-1 Month Momentum % | -81.85 | |||||
| 12-1 Month Momentum % | -94.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.99 | |||||
| Quick Ratio | 1.99 | |||||
| Cash Ratio | 0.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.1 | |||||
| Shareholder Yield % | -21.04 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -56.5 | |||||
| ROA % | -42.52 | |||||
| ROIC % | -107.93 | |||||
| 3-Year ROIIC % | -94.61 | |||||
| ROC (Joel Greenblatt) % | -8562.58 | |||||
| ROCE % | -80.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.36 | |||||
| Price-to-Tangible-Book | 0.71 | |||||
| EV-to-EBIT | -0.72 | |||||
| EV-to-EBITDA | -0.76 | |||||
| EV-to-FCF | -1.46 | |||||
| Price-to-Net-Current-Asset-Value | 0.72 | |||||
| Earnings Yield (Greenblatt) % | -138.89 | |||||
| FCF Yield % | -50 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:QNTM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quantum BioPharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -13 | ||
| Beta | 0.13 | ||
| Volatility % | 68.89 | ||
| 14-Day RSI | 53.55 | ||
| 14-Day ATR ($) | 0.786385 | ||
| 20-Day SMA ($) | 5.4327 | ||
| 12-1 Month Momentum % | -94.09 | ||
| 52-Week Range ($) | 3.5 - 97.499999 | ||
| Shares Outstanding (Mil) | 1.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Quantum BioPharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Quantum BioPharma Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Quantum BioPharma Ltd Frequently Asked Questions
What is Quantum BioPharma Ltd(QNTM)'s stock price today?
The current price of QNTM is $5.63. The 52 week high of QNTM is $97.50 and 52 week low is $3.50.
When is next earnings date of Quantum BioPharma Ltd(QNTM)?
The next earnings date of Quantum BioPharma Ltd(QNTM) is 2024-11-14 Est..
Does Quantum BioPharma Ltd(QNTM) pay dividends? If so, how much?
Quantum BioPharma Ltd(QNTM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers